Literature DB >> 23086625

Prognostic implications of cumulative dosing in total therapy 3.

Bart Barlogie, John Crowley.   

Abstract

Mesh：

Year:  2012        PMID： 23086625      PMCID： PMC3476546          DOI： 10.1182/blood-2012-05-426809

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  1 in total

1.  Total Therapy 3 for multiple myeloma: prognostic implications of cumulative dosing and premature discontinuation of VTD maintenance components, bortezomib, thalidomide, and dexamethasone, relevant to all phases of therapy.

Authors:  Frits van Rhee; Jackie Szymonifka; Elias Anaissie; Bijay Nair; Sarah Waheed; Yazan Alsayed; Nathan Petty; John D Shaughnessy; Antje Hoering; John Crowley; Bart Barlogie
Journal:  Blood       Date:  2010-05-25       Impact factor: 22.113
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.